These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28117835)

  • 21. Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model.
    Silva A; Lee BY; Clemens DL; Kee T; Ding X; Ho CM; Horwitz MA
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2172-9. PubMed ID: 27035987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
    Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
    de Knegt GJ; Bakker-Woudenberg IA; van Soolingen D; Aarnoutse R; Boeree MJ; de Steenwinkel JE
    Int J Antimicrob Agents; 2015 Jul; 46(1):66-72. PubMed ID: 25951996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
    Firsova VA; Poluĕktova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
    Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
    Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem for treatment of tuberculosis in mice and humans.
    Chambers HF; Turner J; Schecter GF; Kawamura M; Hopewell PC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2816-21. PubMed ID: 15980354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
    Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
    J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New drugs for tuberculosis.
    Grassi C; Peona V
    Eur Respir J Suppl; 1995 Sep; 20():714s-718s. PubMed ID: 8590571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    Cynamon M; Sklaney MR; Shoen C
    J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic].
    Isakova ZhT; Goncharova ZK; Iusupova EU; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Chubakov TCh; Alisherov ASh; Aldashev AA
    Probl Tuberk Bolezn Legk; 2007; (4):17-21. PubMed ID: 17657962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.